Teva Pharmaceuticals USA Inc recalls Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint La
Recalled August 17, 2022 · FDA recall D-1334-2022 · Teva Pharmaceuticals USA
Hazard
Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification. · FDA Class III
Units
4162 cartons
Sold at
Distributed in Ohio
Description
Subpotent Drug - Out of specification (OOS) result obtained during monitoring stability study for Assay. Results below specification.
Product
Azacitidine for Injection 100mg/vial Lyophilized Powder, Rx Only, Mfd. in Romania By: Sindan Pharma SRL For BluePoint Laboratories, NDC 68001-313-56
Manufacturer(s)
Teva Pharmaceuticals USA Inc
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →